Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

GRAIL (GRAL) Stock Skyrockets on Samsung’s $110M Bet and Cancer-Screening Breakthrough

GRAIL (GRAL) Stock Skyrockets on Samsung’s $110M Bet and Cancer-Screening Breakthrough

GRAIL’s logo at company headquarters. The Menlo Park biotech specializes in blood-based early cancer screening through its Galleri test news.samsung.com tradingview.com. GRAIL, Inc. is focused on early cancer detection – its mission is “to detect cancer early when it can be cured” news.samsung.com. The company’s Galleri test analyzes tumor DNA in blood to screen for dozens of cancers in asymptomatic adults. Recently, two developments have driven the stock: Samsung’s strategic deal (announced Oct. 16) and positive trial data (released at ESMO). These moves suggest GRAIL is gaining traction, but they also highlight the challenges ahead in turning cutting-edge science into
Disney Stock Could Soar? Analysts Pin 20% Upside on Streaming Shake-Up and Park Growth

Disney Stock Could Soar? Analysts Pin 20% Upside on Streaming Shake-Up and Park Growth

Steady Stock Performance, Mixed Trends Disney’s share price has been relatively flat in 2025 after rallying in 2024. As of Oct. 17 the stock sat around $110.7 marketbeat.com, roughly unchanged from early January. Over the last few days DIS has traded in a narrow $109–112 range stockanalysis.com. Year-to-date Disney is up only ~0.8% benzinga.com, underperforming the broader market rally. In late September and early October the stock dipped into the high-$100s, but analysts say any pullback may present a buying opportunity given Disney’s upcoming catalysts. Trading volumes have been healthy, with recent sessions showing average daily volume (~10–15 million shares).
Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple’s stock is trading near record levels as of mid-October 2025. Last week (Oct. 13–17), AAPL shares oscillated in the $247–$252 range, closing at $252.29 on Oct. 17 historicalstockprice.com. That is only a few dollars below the all-time intraday high (~$260) set in late September ts2.tech historicalstockprice.com. Technically, AAPL is above both its 50-day and 200-day moving averages ts2.tech, signaling positive momentum. However, the stock’s 2025 performance has been muted: it is up only about 1–2% on the year ts2.tech. This flatness contrasts sharply with many other mega-cap tech stocks: for example, Nvidia is +35% YTD, Microsoft +23%, and Alphabet +29% ts2.tech.
GE Aerospace Stock Rockets as Rally Continues – Q3 Earnings, Contracts, and Analyst Targets in Focus

GE Aerospace Stock Rockets as Rally Continues – Q3 Earnings, Contracts, and Analyst Targets in Focus

Surging Stock Performance GE Aerospace (NYSE: GE) shares have been on a tear in 2025, roughly doubling from lows. As of Oct 17, 2025, the stock closed around $300 reuters.com. That’s up about 78% this year intelligentinvestor.com.au – one of the best performances among mega-cap industrials. The 52-week high is $307.25 and the low was $159.36 reuters.com, reflecting a remarkable rebound as the company emerged as a pure-play aerospace engine maker. (Before April 2024, GE had spun off its energy and healthcare units, leaving “GE Aerospace” as its primary business under ticker GE.) Trading volumes have been healthy (typically >1M
IBM Stock Rockets 28%: AI Boom, Quantum Breakthroughs & Big Deals Spark Rally

IBM Stock Rockets 28%: AI Boom, Quantum Breakthroughs & Big Deals Spark Rally

Recent Stock Rally Driven by AI and Quantum News IBM’s stock has rallied sharply in fall 2025. It closed around $279 on Oct 13 ts2.tech, just shy of its late-September peak near $296 ts2.tech. Investors point to IBM’s pivot to AI, cloud and quantum computing as catalysts. In late September, the company announced a first-of-its-kind quantum computing trial with HSBC, which used IBM’s quantum processor to improve bond-trading forecasts by 34% reuters.com. HSBC’s Philip Intallura said the trial is “a tangible example of how today’s quantum computers could solve a real-world business problem at scale” reuters.com. The news (Sept. 25)
Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Stock Surge & Analyst Reaction Atai shares exploded higher on Oct. 17, 2025. Investors bid the stock up ~17.7%, closing at roughly $6.45 ts2.tech (versus ~$5.48 offering price). In after-hours trading it briefly touched ~$6.86 ts2.tech. This rally follows a week of good news: BPL-003’s FDA breakthrough, plus well-received capital raise plans. Volume on Oct. 17 was very high (tens of millions of shares), reflecting heavy trading. Over 2025 the stock has skyrocketed ~348% ts2.tech, making ATAI one of the year’s top biotech performers. Its market cap now hovers around $1.2 billion ts2.tech. Analysts have taken notice. Needham Research just initiated
Cisco Stock Surges Near 52-Week High on AI Momentum – What’s Next for CSCO?

Cisco Stock Surges Near 52-Week High on AI Momentum – What’s Next for CSCO?

CSCO Stock Climbs on Strong Quarter: Cisco’s stock has steadily climbed in 2025, even as many tech peers swung wildly during the AI frenzy. As of mid‑October, CSCO is trading just below its year-high ts2.tech ts2.tech. Over the past week the stock added roughly 2% on investor optimism around recent announcements ts2.tech. Market observers note Cisco’s low volatility (beta <1) and broad support: shares have stayed above key moving averages (50-day ~$68, 200-day ~$65) ts2.tech. “Cisco’s stock has been a steady performer in 2025,” TechStock² (ts2.tech) notes, ~31% higher than a year ago ts2.tech. The company’s market cap is now
New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

Key Stock Metrics: Metric Value (as of Oct 17, 2025) Closing Price $4.55 investing.com 1-Day Change +44.4% (vs $3.15 prev. close) stockanalysis.com Day’s Range $3.20 – $4.71 stockanalysis.com Volume (Oct 17) 33.82 million stockanalysis.com Market Cap ~$129.3 million investing.com 52-Week Range $0.32 – $12.29 stockanalysis.com AI Data Center Pivot Fuels Wild Rally New Era’s stock has rocketed in October thanks to its high-profile push into AI data centers. Mid-September it rebranded from New Era Helium to New Era Energy & Digital, emphasizing its shift into “energy-enabled” digital infrastructure ts2.tech. The company’s 50/50 joint venture, Texas Critical Data Centers (TCDC), is
MindMed Stock Rockets on Breakthrough LSD Anxiety Data – Analysts Eye 100% Upside

MindMed Stock Rockets on Breakthrough LSD Anxiety Data – Analysts Eye 100% Upside

Stock Soars on Catalyst News MindMed’s stock has skyrocketed in recent weeks. After languishing in the single digits, MNMD climbed above $12 in late September and spiked to $13.09 on Oct. 14, its highest level in over a year ts2.tech marketbeat.com. The surge has pushed the stock roughly +68% year-to-date ts2.tech. Heavy trading volume accompanied the rise, as investors reacted to the latest clinical and regulatory news. (By Oct 17, shares were trading around $13.60 stockinvest.us.) This rally has made MindMed one of the year’s best-performing small-cap biotechs. Wall Street sentiment is strongly positive: MarketBeat notes MNMD has seven analyst
18 October 2025
Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

SPCE’s October Volatility: Surge and Selloff In mid-October 2025, Virgin Galactic’s stock was a top mover in the market. After languishing in the low-$3 range, SPCE shares rallied over 40% in early October on a wave of positive news ts2.tech. For example, on Oct. 16 alone the stock jumped about 6% intraday. Trading volume exploded as speculative traders piled in on hopes of new catalysts ts2.tech reuters.com. However, this enthusiasm was met by profit-taking almost immediately: by Oct. 17 the stock plunged 7.9%, erasing much of the gains and closing around $4.08 ts2.tech reuters.com. The volatile swings were driven by Virgin’s history
Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Stock Price and Performance As of mid-October 2025, Sellas Life Sciences (NASDAQ:SLS) trades around $2.10–2.20. This is near the top of its 52-week range ($0.77 low) and about twice its price at the start of 2025 stockanalysis.com marketbeat.com. Trading volume and volatility have picked up – for instance, on Oct. 14 a massive spike in call-option activity (761% above average) coincided with bullish sentiment marketbeat.com. The stock’s YTD gain (~100%) far outpaces many small-cap biotechs. Technical platforms note SLS is in “uptrend” territory: the stock is well above its 20-day EMA ($1.89) and 50-day EMA ($1.81) tipranks.com, which TipRanks flags
Indonesia’s $9B Chinese Fighter Jet Deal Shocks the World

Indonesia’s $9B Chinese Fighter Jet Deal Shocks the World

Indonesia’s abrupt pivot to Chinese fighters has captured global attention. Defense analysts say it underscores Jakarta’s insistence on strategic autonomy. “Foreign actors can spread disinformation, but at the end of the day, Indonesia buys what it chooses,” writes analyst Muhammad Zulfikar Rakhmat asiatimes.com. In practice, Jakarta is “quietly demonstrating that strategic autonomy is possible” – fielding the latest jets from East and West while balancing great-power pressures asiatimes.com. For now, Southeast Asian neighbors and global arms makers will be watching closely how this deal unfolds and how it reshapes the region’s airpower balance. Sources: Official statements and budget documents; reporting
1 122 123 124 125 126 233

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop